Robert M Burkes1, Ralph J Panos1,2, Michael T Borchers1,2. 1. University of Cincinnati College of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine. 2. Cincinnati Veterans' Affairs Medical Center, Cincinnati, Ohio, USA.
Abstract
PURPOSE OF REVIEW: This review discusses emerging therapies directed at chronic obstructive pulmonary disease (COPD) endotypes and pathobiological processes that manifest as the disease. RECENT FINDINGS: Specific endotypes have been targeted in COPD. These include eosinophilic inflammation, overproduction of interleukin-17, chronic bronchitis and altered nature of mucous, and chronic infection. Therapies exactly directed at the cause of these endotypes or their resultant clinical findings have been assessed. Although some intermediate outcomes have seemed promising, there have been no findings that shift the paradigm of COPD therapy. SUMMARY: Basic and clinical scientists continue to define endotypes that may be directly addressed with therapeutics. As of the time of this up-to-date review, there is yet to be an endotype-directed therapy to demonstrate great clinical effect.
PURPOSE OF REVIEW: This review discusses emerging therapies directed at chronic obstructive pulmonary disease (COPD) endotypes and pathobiological processes that manifest as the disease. RECENT FINDINGS: Specific endotypes have been targeted in COPD. These include eosinophilic inflammation, overproduction of interleukin-17, chronic bronchitis and altered nature of mucous, and chronic infection. Therapies exactly directed at the cause of these endotypes or their resultant clinical findings have been assessed. Although some intermediate outcomes have seemed promising, there have been no findings that shift the paradigm of COPD therapy. SUMMARY: Basic and clinical scientists continue to define endotypes that may be directly addressed with therapeutics. As of the time of this up-to-date review, there is yet to be an endotype-directed therapy to demonstrate great clinical effect.
Authors: Marc Miravitlles; Juan José Soler-Cataluña; Myriam Calle; Jesús Molina; Pere Almagro; José Antonio Quintano; Juan Antonio Riesco; Juan Antonio Trigueros; Pascual Piñera; Adolfo Simón; Juan Luis Rodríguez-Hermosa; Esther Marco; Daniel López; Ramon Coll; Roser Coll-Fernández; Miguel Ángel Lobo; Jesús Díez; Joan B Soriano; Julio Ancochea Journal: Arch Bronconeumol Date: 2014-01 Impact factor: 4.872
Authors: William D Bennett; Ashley G Henderson; Agathe Ceppe; Kirby L Zeman; Jihong Wu; Christine Gladman; Fred Fuller; Stephen Gazda; Brian Button; Richard C Boucher; Scott H Donaldson Journal: ERJ Open Res Date: 2020-08-11
Authors: Aran Singanayagam; Nicholas Glanville; Leah Cuthbertson; Nathan W Bartlett; Lydia J Finney; Elena Turek; Eteri Bakhsoliani; Maria Adelaide Calderazzo; Maria-Belen Trujillo-Torralbo; Joseph Footitt; Phillip L James; Peter Fenwick; Samuel V Kemp; Thomas B Clarke; Jadwiga A Wedzicha; Michael R Edwards; Miriam Moffatt; William O Cookson; Patrick Mallia; Sebastian L Johnston Journal: Sci Transl Med Date: 2019-08-28 Impact factor: 17.956
Authors: Dave Singh; Jadwiga A Wedzicha; Salman Siddiqui; Alberto de la Hoz; Wenqiong Xue; Helgo Magnussen; Marc Miravitlles; James D Chalmers; Peter M A Calverley Journal: Respir Res Date: 2020-09-17
Authors: Robert M Burkes; Jacquie Astemborski; Allison A Lambert; Todd T Brown; Robert A Wise; Gregory D Kirk; M Bradley Drummond Journal: PLoS One Date: 2019-02-27 Impact factor: 3.752
Authors: Julien Cohen; Mehdi Shekarnabi; Marie Destors; Renaud Tamisier; Sandrine Bouzon; Maciej Orkisz; Gilbert R Ferretti; Jean-Louis Pépin; Sam Bayat Journal: Front Physiol Date: 2022-05-26 Impact factor: 4.755